FierceBiotechOriginal article
{"a":[{"_":"TME holds onto $1B dream for brain cancer drug as search for partners nears conclusion","$":{"href":"/biotech/tme-holds-1b-dream-brain-cancer-drug-search-partners-nears-conclusion","hreflang":"en"}}]}
PartnershipPositive
AI Analysis
Summary
TME Pharma is nearing completion of its search for a partner for its brain cancer drug and maintains its goal of achieving $1 billion in peak sales from the asset.
Financial Highlights
Guidance
$1 billion in peak sales
Importance:4/10
Sentiment:
0.30
partnershipbrain cancerpeak sales guidanceGerman biotech
Related Companies
Read the original article
Published by FierceBiotech on August 24, 2026 10:15 AM
